Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 12/20 | 0.69 |
| ▸ | PTPN2 | P17706 | 7/20 | 0.69 |
| ▸ | POLB | P06746 | 3/20 | 0.68 |
| ▸ | F3 | P13726 | 3/20 | 0.68 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.68 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.68 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.68 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.68 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.68 |
| ▸ | PTPRC | P08575 | 2/20 | 0.68 |
| ▸ | PTPRF | P10586 | 2/20 | 0.68 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.68 |
| ▸ | CES1 | P23141 | 2/20 | 0.68 |
| ▸ | ACP1 | P24666 | 2/20 | 0.68 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.68 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.68 |
| ▸ | PSMA3 | P25788 | 2/20 | 0.68 |
| ▸ | PSMA4 | P25789 | 2/20 | 0.68 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.68 |
| ▸ | PSMB9 | P28065 | 2/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5799296 | 0.89 | PTPN1 (0.73) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL2586364 | 0.89 | PTPN1 (0.73) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL15687736 | 0.89 | PTPN1 (0.68) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL2397201 | 0.86 | PTPN1 (0.68) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL17044616 | 0.85 | PTPN1 (0.60) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL5797472 | 0.84 | PTPN1 (0.72) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL5799434 | 0.83 | PTPN1 (0.72) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL5799378 | 0.83 | PTPN1 (0.72) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL5795816 | 0.83 | PTPN1 (0.72) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL2941690 | 0.83 | PTPN1 (0.69) | PTPN1PTPN2POLBAKR1B10GPBAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 317 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118924809-A | Traditional Chinese medicine composition for treating and/or preventing osteoporosis and application thereof | 江苏大学 | 2024-11-12 | — | — | CN | claimed |
| CN-117957014-A | ActRII proteins and uses thereof | 阿塞勒隆制药公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117794562-A | ActRII proteins and uses thereof | 阿塞勒隆制药公司 | 2024-03-29 | — | — | CN | claimed |
| CN-115989035-A | ACTRII proteins for the treatment of Pulmonary Arterial Hypertension (PAH) | 阿塞勒隆制药公司 | 2023-04-18 | — | — | CN | claimed |
| CN-113116955-B | Pharmaceutical composition containing plant extracts and application thereof | 中国药科大学 | 2022-10-04 | — | — | CN | claimed |
| CN-113116955-A | Pharmaceutical composition containing plant extracts and application thereof | 中国药科大学 | 2021-07-16 | — | — | CN | claimed |
| US-20210015830-A1 | COMPOSITION FOR INHIBITING REACTIVE OXYGEN SPECIES PRODUCTION | SUNTORY HOLDINGS LIMITED (JP) | 2021-01-21 | — | — | US | claimed |
| CN-111743907-A | Pharmaceutical composition for preventing and treating AD and application thereof | 黑龙江中医药大学 | 2020-10-09 | — | — | CN | claimed |
| CN-111565580-A | Composition for inhibiting generation of active oxygen | 三得利控股株式会社 | 2020-08-21 | — | — | CN | claimed |
| CN-102247420-B | Preparation method and application of eclipta extract | UNIV ZHEJIANG | 2013-01-23 | — | — | CN | claimed |
| CN-102247420-A | Preparation method and application of eclipta extract | UNIV ZHEJIANG | 2011-11-23 | — | — | CN | claimed |
| CN-101347470-A | Glossy privet fruit total triterpenes extract and total phenols extract as well as preparation method thereof | RENBING SHI (CN) | 2009-01-21 | — | — | CN | claimed |
| CN-101167788-A | Quality control method of 'zhenqi fuzheng' containing glossy privet fruit and radix astragali for strengthening the body resistance traditional Chinese medicine for aeipathia deficiency damage and qi | GUIZHOU XINBANG PHARMACY CO LT (CN) | 2008-04-30 | — | — | CN | claimed |
| CN-101053580-A | New medical application of traditional Chinese medicine privet and preparation method of its extraction | UNIV YANSHAN (CN) | 2007-10-17 | — | — | CN | claimed |
| US-20070014739-A1 | Compositions and methods for controlling biofilms and bacterial infections | SEQUOIA SCIENCES, INC. | 2007-01-18 | — | — | US | claimed |
| WO-2006019881-A2 | COMPOSITIONS AND METHODS FOR CONTROLLING BIOFILMS AND BACTERIAL INFECTIONS | ELDRIDGE GARY R (US) | 2006-02-23 | — | — | WO | claimed |
| US-20250195538-A1 | BETULIN-CONTAINING BIRCH BARK EXTRACTS AND THEIR FORMULATION | AMYRT PHARMACEUTICALS DESIGNATED ACTIVITY COMPANY (IE) | 2025-06-19 | — | — | US | disclosed |
| CN-118105453-B | Yang strengthening and hair growing tincture for treating alopecia, and preparation method and application thereof | 南京中医药大学 | 2025-05-09 | — | — | CN | disclosed |
| CN-1203783-A | Preparation of body-building disease-removing bath foam | CAI LANQUAN (CN) | 1999-01-06 | — | — | CN | disclosed |
| CN-1185970-A | External use medicine for vitiligo | SONG SHOUJIN (CN) | 1998-07-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210015830-A1 | COMPOSITION FOR INHIBITING REACTIVE OXYGEN SPECIES PRODUCTION | NOX4, CYBB, NOX1 | PTPN1 1041/4885PTPN2 905/4885POLB 1803/4885 |
| US-20070014739-A1 | Compositions and methods for controlling biofilms and bacterial infections | RHOA, ALOX5, BLVRB | PTPN1 1158/4885PTPN2 1629/4885POLB 2669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.